Drawing for MYREXIS

USPTO serial 77945122

MYREXIS

Reviewed by CopyMark Law Group

Reg. 4049986Status 713
Filing date
Status date
Registration date
Nov 1, 2011
Examiner
GAST, PAUL
Law office
TTAB

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MYREXIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of viral, bacterial, infectious, genetic, auditory, hematological, reproductive, lymphatic, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for use in effecting analgesia and in pain management; pharmaceutical products for the prevention and treatment of cancerSECTION 18 - CANCELLEDMay 19, 2011

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 19, 2016C18.CANCELLED SECTION 18-TOTAL
Feb 19, 2016CANTCANCELLATION TERMINATED NO. 999999
Feb 18, 2016CANGCANCELLATION GRANTED NO. 999999
Oct 15, 2015PETCCANCELLATION INSTITUTED NO. 999999
Nov 1, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 27, 2011SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 26, 2011REGVLAW OFFICE REGISTRATION REVIEW COMPLETED
Sep 26, 2011CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 22, 2011SUPCSTATEMENT OF USE PROCESSING COMPLETE
Sep 20, 2011IUAFUSE AMENDMENT FILED
Sep 20, 2011EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 31, 2011ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 23, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 22, 2011EX1GSOU EXTENSION 1 GRANTED
Mar 22, 2011AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 3, 2011EXT1SOU EXTENSION 1 FILED
Mar 3, 2011MAILPAPER RECEIVED
Sep 21, 2010NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 27, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 27, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 21, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 21, 2010ALIEASSIGNED TO LIE
Jun 4, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 4, 2010XAECEXAMINER'S AMENDMENT ENTERED
Jun 4, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 4, 2010GNEAEXAMINERS AMENDMENT E-MAILED
Jun 4, 2010CNEAEXAMINERS AMENDMENT -WRITTEN
Jun 1, 2010DOCKASSIGNED TO EXAMINER
Mar 3, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 1, 2010NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance